STAT1 and atherosclerosis: Zafar et al found that the STAT1-IRF1 signaling process regulated the expression of pro-inflammatory genes in atherosclerosis, a pathogenic factor in the disease, and that targeted knockdown of IRF1 expression was beneficial in limiting plaque development.[59]